Zusammenfassung
Hintergrund
Eine Beurteilung der Lebensqualität von Patienten in der Augenheilkunde ist nicht nur für Studien und zur Beurteilung neuer Therapien wichtig, sondern gewinnt auch im klinischen Alltag zunehmend für therapeutische Entscheidungen an Bedeutung.
Methoden
Es steht eine Vielzahl von Instrumenten zur Messung der krankheitsübergreifenden (globalen) Lebensqualität zur Verfügung. Ein bekannter Fragebogen hierzu ist der Short Form 36 (SF 36). In der Augenheilkunde werden zur Bestimmung der auf den Sehvorgang bezogenen (visuellen) Lebensqualität spezifischere Instrumente benötigt. Wir geben einen Überblick der praktischen Bedeutung und klinischen Anwendung von Methoden zur Messung der visuellen Lebensqualität. Einige Fragebögen sind der Visual Function 14 (VF-14) oder der National Eye Institute Visual Functioning Questionnaire (NEI-VFQ). Diese werden bislang insbesondere bei häufigen ophthalmologischen Erkrankungen wie Katarakt, altersbedingter Makuladegeneration oder Glaukom eingesetzt. Wichtige Studien hierzu wurden bei einer Literaturrecherche in der Medline-Datenbank identifiziert.
Ergebnisse
Es existiert eine Reihe von Instrumenten zur Messung der visuellen Lebensqualität in der Augenheilkunde. Hohe interne Konsistenz und Validität konnten für viele dieser Instrumente nachgewiesen werden.
Schlussfolgerungen
Die Evaluierung der visuellen Lebensqualität ist ein wichtiger Parameter zur Beurteilung ophthalmologischer Erkrankungen und deren Therapie. Sie sollte von allen in Praxis und Klinik tätigen Augenärzten in alle individuellen klinischen Überlegungen mit einbezogen werden. Zudem ist sie eine bedeutsame Ergebnisvariable in klinischen und ökonomischen Studien.
Abstract
Background
The assessment of patient's quality of life is not only of vital importance for clinical trials of new therapies but also becomes more and more implemented into daily clinical therapeutical decisions.
Methods
Different methods for evaluating quality of life are available. A well-known questionnaire for measuring global quality of life is the Short Form 36 (SF 36). However, in ophthalmology more specific instruments for measuring visual quality of life are needed. We review the usefulness of specific questionnaires such as the Visual Function 14 (VF-14) or the National Eye Institute Visual Function Questionnaire (NEI-VFQ) in their application to common ophthalmologic diseases such as cataract, age-related macular degeneration and glaucoma. Studies applying these methods were identified by a search in the Medline database.
Results
Several instruments to measure visual life quality in ophthalmologic patients are available. Internal consistency and validity are shown.
Conclusions
Evaluating visual quality of life is an important parameter for assessing ophthalmologic diseases and the value of different therapies. It is an important outcome variable in clinical studies. Furthermore, individual visual quality of life should be considered in individual therapeutic decisions and helps to assess the economic effect of current and new therapies.
Literatur
Boisjoly H, Gresset J, Fontaine N et al. (1999) The VF-14 index of functional visual impairment in candidates for a corneal graft. Am J Ophthalmol 128:38–44
Broman AT, Munoz B, Rodriguez J et al. (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci 43:3393–3398
Brubaker RF (1999) Decisions. Ophthalmology 1:165–168
Brüggenjürgen B (1994) Lebensqualität und volkswirtschafliche Kosten der Migräne in Deutschland. Sankt Augustin
Bullinger M (1993) Indices versus profiles: advantages and disadvantages. In: Walker SR, Rosse RM (eds) Quality of life assessment. Key issues in the 1990s. MTP Press, Lancester, S 209–220
Cassard SD, Patrick DL, Damiano AM et al. (1995) Reproducibility and responsiveness of the VF-14: an index of functional impairment in patients with cataracts. Arch Ophthalmol 113:1508–1513
Drummond MF, Stoddart GL, Torrance, GW (1987) Methods for the Economic Evaluation of Health Care Programmes Oxford [Oxfordshire]. Oxford University Press, New York
Early Treatment Diabetic Retinopathy Study Research Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 94:761–774
Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Report Number 9. Ophthalmology 98:766–785
EuroQol Group (1990) EuroQol—A new facility for the measurement of health-related quality of life. Health Policy 16:199–208
Gutierrez P, Wilson MR, Johnson C et al. (1997) Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115:777–784
Hart PM, Chakravarthy U, Stevenson MR, Jamison JQ (1999) A vision specific functional index for use in patients with age related macular degeneration. Br J Ophthalmol 83:1115–1120
Hyman L, Schachat AP, He Q, Leske MC (2000) Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118:351–358
Johannesson M, Jönsson B, Karlsson G (1996) Outcome measurement in economic evaluation. Health Economics 5:279–296
Klein R, Rowland ML, Harris MI (1995) Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 102:371–381
Linder M, Chang TS, Scott IU et al. (1999) Validity of the Visual Function Index (VF-14) in patients with retinal disease. Arch Ophthalmol 117:1611–1616
Mackenzie PJ, Chang TS, Scott IU et al. (2002) Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology 109:720–729
Mangione CM, Phillips RS, Seddon JM et al. (1992) Development of the activities of Daily Vision Scale: a measure of visual functional status. Med Care 30:1111–1126
Mangione CM, Phillips RS, Lawrence MG et al. (1994) Improved visual function and attenuation of declines in health related quality of life after cataract extractation. Arch Ophthalmol 112:1419–1425
Mangione CM, Lee PP, Berry SH et al. (1995) Development of a questionnaire for assessment of visual function: association for Research in vision and ophthalmology. Invest Ophthalmol Vis Sci 36:1962
Mangione CM, Lee PP, Berry SH et al. (1996) The NEI-VFQ 51-item test version and its relationship with visual acuity across 5 diseases: association for research in vision and ophthalmology. Invest Ophthalmol Vis Sci 37:873
Mangione CM, Berry S, Spritzer K (1998) Identifying the content area for the 51-item National Eye Institut Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227–233
McClure ME, Hart PM, Jackson AJ et al. (2000) Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 84:244–250
Musch DC, Farjo AA, Meyer RF et al. (1997) Assessment of health-related quality of life after corneal transplantation. Am J Ophthalmol 124:1–8
Neubauer AS, Mueller AJ, Schriever S et al. (2000) Minimally invasive therapy for clinically complete central retinal artery occlusion- results and meta-analysis of literature. Klin Monatsbl Augenheilkd 217:30–36
Parrish RK, Gedde SJ, Scott IU et al. (1997) Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115:1447–1455
Patrick DL, Erickson P (1993) Assessing health-related quality of life for clinical decision making. In Walker SR, Rosse RM (eds) Quality of life assessment. Key issues in the 1990s. MTP Press, Lancester, S 11–63
Pesudovs K, Elliott DB, Gelsthorpe SD et al. (2002) The development of the Quality of Life Impact of Refractive Correction (QIRC) Questionnaire. Poster ARVO
Schöffski O (1998) Gesundheitsökonomische Evaluationen: Grundlagen und Standortbestimmung. Springer Verlag, Berlin Heidelberg New York Tokyo
Scott IU, Smiddy WE, Schiffman J et al. (1999) Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 128:54–62
Sharma S, Brown GC, Brown MM et al. (2001) The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 110:626–627
Stadnyk K, Caldere J, Rockwood K (1998) Testing the measurement properties of the Short Form–36 in a frail elderly population. J Clin Epidemiol 51:827–835
Steinberg EP, Tielsch JM, Schein OD et al. (1994) The VF-14: an index of functional impairment in cataract patients. Arch Ophthalmol 112:630–638
The Diabetic Retinopathy Study Research Group (1987) Indications for photocoagulation treatment of diabetic retinopathy. Diabetic Retinopathy Study Report Number 14. Int Ophthalmol Clin 27:293–353
Torrance GW (1986) Measurement of health state utilities for economic appraisal. A review. J Health Economics 5:1–30
University of Oxford, Centre for Evidence based Medicine. "Levels of evidence and Grades of Recommendations". http://www.cebm.net
Ware JE, Snow KK, Kosinski M, Gandek V (1993) SF-36 Health Survey Manual and Interpretation Guide. Nimrod Press, Boston
Wolffsohn JS, Cochrane AL (2000) Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation, Am J Ophthalmol 130:793–802
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirneiß, C., Neubauer, A.S., Welge-Lüßen, U. et al. Bestimmung der Lebensqualität des Patienten in der Augenheilkunde. Ophthalmologe 100, 1091–1097 (2003). https://doi.org/10.1007/s00347-003-0884-1
Issue Date:
DOI: https://doi.org/10.1007/s00347-003-0884-1